IGF1 and obstructive sleep apnea syndrome: The meta-analysis outcomes revealed that IGF-1 levels in patients with OSAHS were significantly lower than those of healthy controls (SMD= -1.32, 95%CI= -1.71–0.92, P< 0.001; Figure 2).